Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma.Yılmaz İ, Paçacı Çetin G, Arslan B, Şeker S, Bozkurt Yılmaz HE, Aktaş Yapıcı E, Köylüce S, Açar E. Tuberk Toraks. 2023 Mar;71(1):75-93. doi: 10.5578/tt.20239910.
Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma. Yılmaz İ, Çetin GP, Arslan B. J Allergy Clin Immunol Pract. 2022 Jul;10(7):1935-1936. doi: 10.1016/j.jaip.2022.04.017.
The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma. Arslan B, Çetin GP, Yilmaz İ. J Aerosol Med Pulm Drug Deliv. 2023 Aug;36(4):189-209. doi: 10.1089/jamp.2022.0059. Epub 2023 Jul 11
[Biologics for the treatment of severe asthma: Current status report 2023]. Paçacı Çetin G, Kepil Özdemir S, Can Bostan Ö, Öztop N, Çelebi Sözener Z, Karakaya G, Gelincik Akkor A, Yılmaz İ, Mungan D, Bavbek S. Tuberk Toraks. 2023 Jun;71(2):176-187. doi: 10.5578/tt.20239921.
Picturing asthma in Turkey: results from the Turkish adult asthma registry. Celik GE, Aydin O, Gokmen D, Koycu Buhari G, Celebi Sozener Z, Gemicioglu B, Bulut I, Beyaz S, Orcen C, Ozdemir SK, Keren M, Damadoglu E, Yakut T, Kalpaklioglu AF, Baccioglu A, Yalim SA, Yilmaz I, Koca Kalkan I, Uysal MA, Ozgun Niksarlioglu EY, Kalyoncu AF, Karakaya G, Erbay M, Nayci S, Tepetam FM, Gelincik AA, Dirol H, Goksel O, Karaoglanoglu S, Oner Erkekol F, Isik SR, Yildiz F, Yavuz Y, Karadogan D, Bozkurt N, Seker U, Oguzulgen IK, Basyigit I, Baris SA, Yilmazel Ucar E, Erdogan T, Polatli M, Ediger D, Gunaydin FE, Turk M, Pur L, Katran ZY, Sekibag Y, Aykac EF, Mungan D, Gul O, Cengiz A, Akkurt B, Ozden S, Demir S, Unal D, Aslan AF, Can A, Gumusburun R, Bogatekin G, Akten HS, Inan S, Erdinc M, Ogus AC, Kavas M, Polat Yulug D, Cakmak ME, Kaya SB, Alpagat G, Ozgur ES, Uzun O, Tas Gulen S, Pekbak G, Kizilirmak D, Havlucu Y, Donmez H, Arslan B, Cetin GP, Soyyigit S, Kara BY, Pasaoglu Karakis G, Dursun AB, Kendirlinan R, Ozturk AB, Sevinc C, Omeroglu Simsek G, Abadoglu O, Cerci P, Yucel T, Yorulmaz I, Tezcaner ZC, Tatar EC, Suslu AE, Ozer S, Dursun E, Yorgancioglu A. J Asthma. 2023 Nov;60(11):1973-1986. doi: 10.1080/02770903.2023.2206902. Epub 2023 May 31.
Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma. Paçacı Çetin G, Arslan B, Yılmaz İ. J Asthma. 2023 Jul 20:1-7. doi: 10.1080/02770903.2023.2236696.
Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group. Çelik GE, Aydın Ö, Damadoğlu E, Baççıoğlu A, Kepil Özdemir S, Bavbek S, Ediger D, Öner Erkekol F, Gemicioğlu B, Işık SR, Kalpaklıoğlu AF, Kalyoncu AF, Karakaya G, Keren M, Mungan D, Oğuzülgen İK, Yıldız F, Yılmaz İ, Yorgancıoğlu A. Thorac Res Pract. 2023 Nov;24(6):309-324. doi: 10.5152/ThoracResPract.2023.23035.
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease. Celebi Sozener Z, Ozdel Ozturk B, Cerci P, Turk M, Gorgulu Akin B, Akdis M, Altiner S, Ozbey U, Ogulur I, Mitamura Y, Yilmaz I, Nadeau K, Ozdemir C, Mungan D, Akdis CA. Allergy. 2022 May;77(5):1418-1449. doi: 10.1111/all.15240. Epub 2022 Feb 16.
The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis. Celebi Sozener Z, Özbey Yücel Ü, Altiner S, Ozdel Oztürk B, Cerci P, Türk M, Gorgülü Akin B, Akdis M, Yilmaz I, Ozdemir C, Mungan D, Akdis CA. Front Allergy. 2022 Jul 8;3:887672. doi: 10.3389/falgy.2022.887672. eCollection 2022.
Classification of asthma severity: Severe/not severe asthma or mild/moderate/severe asthma? Yılmaz İ, Paçacı Çetin G, Arslan B. Tuberk Toraks. 2022 Sep;70(3):300-301. doi: 10.5578/tt.20229711.
Are we entering an era of combined biologic use for severe asthma? Arslan B, Şeker S, Yılmaz İ. Tuberk Toraks. 2022 Dec;70(4):403-404. doi: 10.5578/tt.20229613.
The adequacy of current diagnostic criteria for making a diagnosis of ABPA. Nazik Bahçecioğlu S, Türk M, Paçacı Çetin G, Yılmaz İ. Tuberk Toraks. 2022 Jun;70(2):141-148. doi: 10.5578/tt.20229804.
Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance? Türk M, Yılmaz İ, Şahiner ÜM, Kocatürk E, Şekerel BE, Zuberbier T, Maurer M. Allergy. 2022 May;77(5):1626-1630. doi: 10.1111/all.15227. Epub 2022 Jan 28.
Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma. Türk M, Yılmaz İ, Gökahmetoğlu S, Koç AN. Turk J Med Sci. 2022 Aug;52(4):1148-1159. doi: 10.55730/1300-0144.5418. Epub 2022 Aug 10.
Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT. Çetin GP, Yılmaz İ, Türk M, Arslan B, Bahçecioğlu SN. Turk J Med Sci. 2022 Aug;52(4):1223-1234. doi: 10.55730/1300-0144.5427. Epub 2022 Aug 10.
Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment? Arslan B, Paçacı Çetin G, Türk M, Gülmez İ, Yılmaz İ. Int Arch Allergy Immunol. 2022;183(10):1071-1077. doi: 10.1159/000525723. Epub 2022 Aug 2.
[Long-term macrolide therapy in asthma]. Paçacı Çetin G, Arslan B, Yılmaz İ. Tuberk Toraks. 2021 Dec;69(4):520-534. doi: 10.5578/tt.20219610.
Asthma phenotype and endotype definitions. Yılmaz İ, Paçacı Çetin G. Tuberk Toraks. 2021 Jun;69(2):288-290. doi: 10.5578/tt.20219821.
[Type 2 inflammation in asthma]. Yılmaz İ, Arslan B. Tuberk Toraks. 2021 Mar;69(1):114-115. doi: 10.5578/tt.20219916.
Blood hyperreosinophilia: A diagnostic challenge. Paçacı Çetin G, Köse M, Arslan B, Yılmaz İ. Tuberk Toraks. 2021 Sep;69(3):408-415. doi: 10.5578/tt.20219715.
The Visible and Invisible Faces of the Iceberg of Type 2 Asthma. Yılmaz İ, Çetin GP. Am J Respir Crit Care Med. 2021 Jun 1;203(11):1443-1444. doi: 10.1164/rccm.202102-0291LE.
Current approach to the diagnosis of allergic bronchopulmonary aspergillosis. Türk M, Nazik Bahçecioğlu S, Yılmaz İ. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2546. doi: 10.1016/j.jaip.2021.03.024.
Type 2 chronic rhinosinusitis with nasal polyps: From phenotype to endotype. Yılmaz İ. J Allergy Clin Immunol Pract. 2021 Jan;9(1):600-601. doi: 10.1016/j.jaip.2020.11.009.
Worsening of chronic spontaneous urticaria after intake of hot pepper. Türk M, Yılmaz İ, Hawro T, Maurer M. Asian Pac J Allergy Immunol. 2021 Mar;39(1):25-30. doi: 10.12932/AP-280819-0632.
Frequency of peripheral blood eosinophilia and obstructive airway disease in sarcoidosis. Rabahoğlu B, Oymak FS, Baran Ketencioğlu B, Tutar N, Gülmez İ, Yılmaz İ. Turk J Med Sci. 2021 Dec;51(6):3001-3007. Epub 2021 Dec 13.
Biologics for oral corticosteroid-dependent asthma. Yılmaz İ. Allergy Asthma Proc. 2020 May 1;41(3):151-157. doi: 10.2500/aap.2020.41.200015.
Non-Infectious Diseases Compatible With COVID-19 Pneumonia. Baran Ketencioğlu B, Yiğit F, Almadqa M, Tutar N, Yılmaz İ. Cureus. 2020 Aug 24;12(8):e9989. doi: 10.7759/cureus.9989.
Horse allergen sensitivity and respiratory symptoms among horse farm workers. Baran Ketencioğlu B, Yilmaz I, Tutar N, Gülmez I, Oymak FS. Turk J Med Sci. 2020 Jun 23;50(4):910-916. doi: 10.3906/sag-1912-39.
Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy. Yılmaz İ. Chest. 2020 Nov;158(5):2229-2230. doi: 10.1016/j.chest.2020.05.612.
The protective effects of thymoquinone on lung damage caused by cigarette smoke. Yetkin NA, Büyükoğlan H, Sönmez MF, Tutar N, Gülmez I, Yilmaz I. Biotech Histochem. 2020 May;95(4):268-275. doi: 10.1080/10520295.2019.1681511. Epub 2019 Nov 5.
Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment. Türk M, Yılmaz İ, Nazik Bahçecioğlu S, Can P, Ertaş R, Kartal D, Çınar SL, Kocatürk E. Dermatol Ther. 2021 Jan;34(1):e14543. doi: 10.1111/dth.14543. Epub 2020 Nov 22.
High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison? Türk M, Yılmaz İ. Int Arch Allergy Immunol. 2021;182(5):461-462. doi: 10.1159/000512373. Epub 2020 Dec 15.
The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough. Yılmaz İ, Türk M, Baran Ketencioğlu B, Çetinkaya Z, Tutar N, Oymak FS, Gülmez İ, Adkinson NF. Clin Respir J. 2020 Apr;14(4):382-388. doi: 10.1111/crj.13143. Epub 2020 Jan 14.
Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study. Yilmaz I, Türk M, Nazik Bahçecioğlu S, Tutar N, Gülmez I. Turk J Med Sci. 2020 Apr 9;50(2):433-441. doi: 10.3906/sag-1912-62.
Angiotensin-Converting Enzyme Inhibitors Induce Cough. Yılmaz İ. Turk Thorac J. 2019 Jan 1;20(1):36-42. doi: 10.5152/TurkThoracJ.2018.18014.
Eosinophilic asthma with chronic rhinosinusitis/nasal polyps and biologic agents. Yilmaz İ. Tuberk Toraks. 2019 Dec;67(4):292-299. doi: 10.5578/tt.68953.
Selection of Biologics for Type 2-High Asthma. Yilmaz I. Am J Respir Crit Care Med. 2019 Sep 15;200(6):790-791. doi: 10.1164/rccm.201904-0763LE.
How to discontinue omalizumab in chronic spontaneous urticaria? Türk M, Maurer M, Yılmaz İ. Allergy. 2019 Apr;74(4):821-824. doi: 10.1111/all.13675. Epub 2018 Dec 28.
Urticaria control test might misevaluate disease control in particular patients treated with omalizumab. Türk M, Yılmaz İ. Ann Allergy Asthma Immunol. 2019 Mar;122(3):342-343. doi: 10.1016/j.anai.2018.11.024. Epub 2018 Dec 4.
The protective effects of thymoquinone on lung damage caused by cigarette smoke. Yetkin NA, Büyükoğlan H, Sönmez MF, Tutar N, Gülmez I, Yilmaz I. Biotech Histochem. 2020 May;95(4):268-275. doi: 10.1080/10520295.2019.1681511. Epub 2019 Nov 5. PMID: 31687851
Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia. Yılmaz I, Bahçecioğlu SN, Türk M, Tutar N, Oymak FS, Gülmez İ. J Asthma. 2019 Feb;56(2):111-117. doi: 10.1080/02770903.2018.1443469. Epub 2018 Apr 3. PMID: 29611776
How to discontinue omalizumab in chronic spontaneous urticaria? Türk M, Maurer M, Yılmaz İ. Allergy. 2019 Apr;74(4):821-824. doi: 10.1111/all.13675. Epub 2018 Dec 28.
Is Asthma-COPD overlap an asthma phenotype or a COPD phenotype? Yılmaz İ. Tuberk Toraks. 2018 Mar;66(1):78-79. doi: 10.5578/tt.66337.
Biologic Targeted Therapies for the Phenotypes of Type-2 High Severe Asthma. Yılmaz İ, Türk M. J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1091-1092. doi: 10.1016/j.jaip.2017.12.034.
Combination of omalizumab and bee venom immunotherapy: does it work? Yılmaz İ, Bahçecioğlu SN, Türk M. Asia Pac Allergy. 2018 Jan 9;8(1):e2. doi: 10.5415/apallergy.2018.8.e2. eCollection 2018 Jan.
Urticaria control test might misevaluate disease control in particular patients treated with omalizumab. Türk M, Yılmaz İ. Ann Allergy Asthma Immunol. 2019 Mar;122(3):342-343. doi: 10.1016/j.anai.2018.11.024. Epub 2018 Dec 4.
Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria. Türk M, Kocatürk E, Cüre K, Yılmaz İ. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1389-1390. doi: 10.1016/j.jaip.2018.01.027. Epub 2018 Feb 2.
Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients. Türk M, Yılmaz İ, Bahçecioğlu SN. Allergol Int. 2018 Jan;67(1):85-89. doi: 10.1016/j.alit.2017.05.003. Epub 2017 May 26.
Confusing Terminology: Difficult Asthma, Difficult-to-Treat Asthma, Difficult-to-Control Asthma, Therapy-Resistant Asthma, Severe Asthma, and Refractory Asthma. Which One is Truly Severe Asthma? Yılmaz İ. Turk Thorac J. 2018 Sep 13;19(4):235-236. doi: 10.5152/TurkThoracJ.2018.18026. Print 2018 Oct.
Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients. Türk M, Bahçecioğlu SN, Tutar N, Oymak FS, Gülmez İ, Yılmaz İ. Turk Thorac J. 2018 Sep 13;19(4):187-192. doi: 10.5152/TurkThoracJ.2018.17109. Print 2018 Oct.
Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia. Yılmaz I, Bahçecioğlu SN, Türk M, Tutar N, Oymak FS, Gülmez İ. J Asthma. 2019 Feb;56(2):111-117. doi: 10.1080/02770903.2018.1443469. Epub 2018 Apr 3.
Non-asbestos-related malignant pleural mesothelioma. Kanbay A, Ozer Simsek Z, Tutar N, Yılmaz I, Buyukoglan H, Canoz O, Demir R. Intern Med. 2014;53(17):1977-9. doi: 10.2169/internalmedicine.53.0900. Epub 2014 Sep 1.
Peripartum genital tuberculosis presenting with ascites. Dogan S, Celikbilek M, Topaloglu US, Canoz O, Yilmaz I, Yurci A, Ozbakir O. Clin J Gastroenterol. 2014 Feb;7(1):27-31. doi: 10.1007/s12328-013-0439-1. Epub 2013 Nov 27.
Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation. Yılmaz İ, Türk M. Turk Thorac J. 2017 Jul;18(3):94-95. doi: 10.5152/TurkThoracJ.2017.17002. Epub 2017 Jul 1.
Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes. Yılmaz İ, Türk M, Bahçecioğlu SN. Autoimmun Rev. 2017 Sep;16(9):992-993. doi: 10.1016/j.autrev.2017.07.010. Epub 2017 Jul 13.
Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station? Yılmaz İ, Türk M, Bahçecioğlu SN. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1807-1808. doi: 10.1016/j.jaip.2017.07.048.
Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib. Yılmaz İ, Kaynar L, Tutar N, Pala Ç, Canöz Ö, Yıldırım A, Büyükoğlan H, Gülmez İ. Turk Thorac J. 2016 Jul;17(3):118-121. doi: 10.5578/ttj.30508. Epub 2016 Jul 1.
Comment on: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives". Yılmaz İ, Türk M. Drugs. 2017 Nov;77(17):1925-1926. doi: 10.1007/s40265-017-0821-2.
What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease? Yilmaz I, Turk M. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1229-1230. doi: 10.1164/rccm.201705-0892LE.
Evaluation of drug provocation test-related anxiety in patients with drug hypersensitivity. Soyyiğit Ş, Aydın Ö, Yılmaz İ, Özdemir SK, Cankorur VŞ, Atbaşoğlu C, Çelik GE. Ann Allergy Asthma Immunol. 2016 Sep;117(3):280-4. doi: 10.1016/j.anai.2016.06.016. Epub 2016 Jul 1.
Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients. Türk M, Yılmaz İ, Bahçecioğlu SN. Allergol Int. 2018 Jan;67(1):85-89. doi: 10.1016/j.alit.2017.05.003. Epub 2017 May 26.
Omalizumab in severe asthma with seasonal allergic sensitization M Türk, N Tutar, İ Yılmaz Revue Française d'Allergologie 63 (5), 103675
Usage of biomarkers in the treatment of chronic spontaneous urticaria HEB Yılmaz, GP Çetin, İ Yılmaz Revue Française d'Allergologie 63 (4), 103347
Can clarithromycin be used without testing in patients with penicillin allergy? B Arslan, GP Çetin, İ Yılmaz Revue Française d'Allergologie 63 (4), 103615
Safety Profiles of Biological Therapies Used in Asthma Treatment GP ÇETIN, B ARSLAN, İ YILMAZ Asthma Allergy Immunology 20 (3), 127-141
Safety Profiles of Biological Therapies Used in Asthma Treatment. G PAÇACI ÇETIN, B ARSLAN, I YILMAZ Asthma Allergy Immunology/Astim Allerji Immunoloji 20 (3)
Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study. S NAZİK BAHÇECİOĞLU, M TÜRK, E ATAYIK, G PAÇACI ÇETİN, ... Asthma Allergy Immunology/Astim Allerji Immunoloji 20 (2)
Idiopathic anaphylaxis: hereditary angioedema in the differential diagnosis İ YILMAZ, N TUTAR, H BÜYÜKOĞLAN, İ GÜLMEZ, S OYMAK, R DEMİR Asthma Allergy Immunology 11 (1), 053-058
Assessment of CD63 and CD203c Basophil Activation Tests in Patients with Immediate Drug Hypersensitivity Reaction to Rocuronium F Dogruel, D Günay Canpolat, S Özsoy, T Rıhtım, MY Koker, I Yilmaz JOURNAL OF CLINICAL PRACTICE AND RESEARCH 45 (1), 25-31
Mikrobiyom ve Astım B Arslan, İ Yılmaz Güncel Göğis Hastalıkları Serisi 8 (2), 15-27
A Rare Case of Multiple Severe Anaphylaxis Caused by Thyme, Black Pepper, Wasp and Honey M Türk, İ YILMAZ ASTIM ALLERJI IMMUNOLOJI 17 (2)
Local anesthetics allergy: who should be tested? İ YILMAZ, S Ozdemir, Ö AYDIN, G ÇELİK European Annals of Allergy and Clinical Immunology 50 (2)
Deri Yama Testi ile Doğrulanan Tenoksikamın Neden Olduğu Fiks İlaç Erüpsiyonu. İ YILMAZ, N Tutar, S Yenigün, Z ÖZER ŞİMŞEK, İ Gülmez Asthma Allergy Immunology/Astim Allerji Immunoloji 15 (3)
Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction. I Yilmaz, M Türk, N Bahçecioğlu European Annals of Allergy and Clinical Immunology 50 (2), 94-96
Astımı ve Buğday Unu Gıda Allerjisi Olan Bir Fırıncı İ Yılmaz, D Mungan Asthma Allergy Immunology 15 (2), 107-110
Successful Desensitization in a Patient with Hypersensitivity Reaction to Laronidase İ Yılmaz, AS Çağlar, F Kardas, Z Karaca, S Yenigun, N Tutar Pediatric Allergy, Immunology, and Pulmonology 30 (1), 64-66
Tenoxicam-Induced Fixed Drug Eruption Confirmed by Skin Patch Test İ Yilmaz, N Tutar, S Yenigun, Z Simsek, İ Gülmez ASTIM ALLERJI IMMUNOLOJI 15 (3)
Bronş Provokasyon Testleri İ YILMAZ Dünya Tıp Kitabevi
A baker with asthma and wheat flour food allergy İ Yilmaz, D Mungan ASTIM ALLERJI IMMUNOLOJI 15 (2)
Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome I Yilmaz, L Kaynar, N Tutar, C Pala, O Canoz, H Buyukoglan, I Gulmez Revista Portuguesa de Pneumología 22 (1), 59-60
How do patients with asthma and COPD behave during fasting? Ö Aydin, GE Celik, ZP Önen, İ Yilmaz, SK Özdemir, Ö Yildiz, D Mungan, ... Allergologia et immunopathologia 42 (2), 115-119
Sık rastlanan bir mesleksel astım tipi: Fırıncı astımı. İ YILMAZ, D Mungan Asthma Allergy Immunology/Astim Allerji Immunoloji 11 (3)
Does drug compliance change in asthmatic patients during pregnancy? I Yilmaz, FO Erkekol, S Celen, MZ Karaca, O Aydin, G Celik, Z Misirligil, ... Multidisciplinary Respiratory Medicine 8, 1-4
Cat and dog sensitization in pet shop workers I Yilmaz, F Oner Erkekol, D Secil, Z Misirligil, D Mungan Occupational medicine 63 (8), 563-567
Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients. Yılmaz İ, Çelik G, Aydın Ö, Özdemir SK, Soyyiğit Ş, Sözener Z, Özgüçlü S, Atasoy Ç, Düzgün N, Mungan D, Sin B, Demirel YS, Mısırlıgil Z. Clin Respir J. 2015 Jul;9(3):350-8. doi: 10.1111/crj.12154. Epub 2014 May 19.
Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function? Tutar N, Kemik NA, Yılmaz I, Büyükoğlan H, Kanbay A, Dogan A, Oyak FS, Gülmez I, Demir R. Clin Appl Thromb Hemost. 2015 Sep;21(6):533-8. doi: 10.1177/1076029613512416. Epub 2013 Nov 19.
Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity. Bavbek S, Kepil Özdemir S, Doğanay Erdoğan B, Karaboğa I, Büyüköztürk S, Gelincik A, Yılmaz İ, Göksel Ö, Dursun AB, Karakaya G, Kalyoncu AF, Özşeker F, Paşaoğlu Karakış G, Öner Erkekol F, Köycü G, Keren M, Baiardini I, Romano A. Qual Life Res. 2016 Jan;25(1):101-9. doi: 10.1007/s11136-015-1051-2. Epub 2015 Jun 20.
The Association of Brain-Derived Neurotrophic Factor Gene Polymorphism with Obstructive Sleep Apnea Syndrome and Obesity. Yüksekkaya M, Tutar N, Büyükoğlan H, Dündar M, Yılmaz İ, Gülmez İ, Oymak FS, Balta B, Korkmaz K, Demir R. Lung. 2016 Oct;194(5):839-46. doi: 10.1007/s00408-016-9894-z. Epub 2016 May 11.
Is nonhomogeneous expression of tissue mast cells or allergen specific IgEs bound to tissue mast cells possible? Türk M, Bahçecioğlu SN, Yılmaz İ. Asia Pac Allergy. 2017 Jul;7(3):179-181. doi: 10.5415/apallergy.2017.7.3.179. Epub 2017 Jul 26.
Clinical and Serological Features of Eosinophilic and Vasculitic Phases of Eosinophilic Granulomatosis with Poliangiitis: a Case Series of 15 Patients. Yılmaz İ, Tutar N, Şimşek ZÖ, Oymak FS, Gülmez İ. Turk Thorac J. 2017 Jul;18(3):72-77. doi: 10.5152/TurkThoracJ.2017.16040. Epub 2017 Jul 1.
Learning curve of conventional transbronchial needle aspiration. Tutar N, Büyükoğlan H, Yılmaz I, Kanbay A, Onal O, Bilgin M, Canöz O, Demir R, Oyak FS, Gülmez I, Cetinkaya E. Clin Respir J. 2014 Jan;8(1):79-85. doi: 10.1111/crj.12041. Epub 2013 Oct 1.
Biphasic anaphylaxis to gemifloxacin. Yilmaz I, Doğan S, Tutar N, Kanbay A, Büyükoğlan H, Demir R. Asia Pac Allergy. 2012 Oct;2(4):280-2. doi: 10.5415/apallergy.2012.2.4.280. Epub 2012 Oct 31.
Late onset anaphylaxis in a hydatid cyst case presenting with chronic urticaria. Yilmaz I, Aydin O, Okoh A, Misirligil Z. Case Rep Med. 2013;2013:658393. doi: 10.1155/2013/658393. Epub 2013 Jul 11.
Does drug compliance change in asthmatic patients during pregnancy? Yilmaz I, Erkekol FO, Celen S, Karaca MZ, Aydin O, Celik G, Misirligil Z, Mungan D. Multidiscip Respir Med. 2013 Jun 11;8(1):38. doi: 10.1186/2049-6958-8-38.
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Tutar N, Metan G, Koç AN, Yilmaz I, Bozkurt I, Simsek ZO, Buyukoglan H, Kanbay A, Oymak FS, Gulmez I, Demir R. Multidiscip Respir Med. 2013 Sep 4;8(1):59. doi: 10.1186/2049-6958-8-59. eCollection 2013.
The validation of the Turkish version of Asthma Control Test. Uysal MA, Mungan D, Yorgancioglu A, Yildiz F, Akgun M, Gemicioglu B, Turktas H; Turkish Asthma Control Test (TACT) Study Group. Qual Life Res. 2013 Sep;22(7):1773-9. doi: 10.1007/s11136-012-0309-1. Epub 2012 Nov 10.
Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization. Bavbek S, Yılmaz I, Aydın Ö, Ozdemir SK. Int Arch Allergy Immunol. 2012;157(2):209-12. doi: 10.1159/000327537. Epub 2011 Oct 7.
Self-reported knowledge and approaches toward complementary and alternative medicine among physicians dealing with allergic diseases. Argüder E, Yilmaz I, Ateş C, Misirligil Z, Bavbek S. Am J Chin Med. 2012;40(4):671-83. doi: 10.1142/S0192415X12500504.
Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function? Tutar N, Kemik NA, Yılmaz I, Büyükoğlan H, Kanbay A, Dogan A, Oyak FS, Gülmez I, Demir R. Clin Appl Thromb Hemost. 2015 Sep;21(6):533-8. doi: 10.1177/1076029613512416. Epub 2013 Nov 19.
[Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet's Disease]. Yılmaz I, Cağlar B, Akay BN, Alkız G, Boyvat A, Akyol A. Turkiye Parazitol Derg. 2013;37(2):139-42. doi: 10.5152/tpd.2013.30.
Fixed drug eruption caused by ornidazole and fluconazole but not isoconazole, itraconazole, ketoconazole and metronidazole. Bavbek S, Yilmaz İ, Sözener ZÇ. J Dermatol. 2013 Feb;40(2):134-5. doi: 10.1111/1346-8138.12023. Epub 2012 Oct 30.
Asthma control test via text messaging: could it be a tool for evaluating asthma control? Uysal MA, Mungan D, Yorgancioglu A, Yildiz F, Akgun M, Gemicioglu B, Turktas H; Study Group, Turkish Asthma Control Test (TACT), Turkey. J Asthma. 2013 Dec;50(10):1083-9. doi: 10.3109/02770903.2013.832294. Epub 2013 Sep 19.
Evaluation of vascular endothelial growth factor A and endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis. Yılmaz I, Bayraktar N, Ceyhan K, Seçil D, Yüksel S, Mısırlıgil Z, Bavbek S. Am J Rhinol Allergy. 2013 May-Jun;27(3):181-6. doi: 10.2500/ajra.2013.27.3867.
[Therapy with omalizumab in patients with severe persistent allergic asthma: a real life data in Turkey]. Bavbek S, Aydın O, Kepil Özdemir S, Yılmaz I, Celik GE, Demirel YS, Mungan D, Sin B, Kurşun N, Mısırlıgil Z. Tuberk Toraks. 2010;58(4):425-34.
Fire-eater's pneumonia after aspiration of liquid paraffin. Karacan O, Yilmaz I, Eyüboğlu FO. Turk J Pediatr. 2006 Jan-Mar;48(1):85-8.
Sağlık çalışanlarında asemptomatik atopi sıklığı ve latent tüberküloz ile ilişkisi İ Yılmaz, Ş Akçay, Ö Türkkan, B Bozkurt Asthma Allergy Immunology 11 (1), 43-48
Triggers of asthma and COPD: Are they different? Ö Aydin, GE Çelik, ZP Önen, İ Yilmaz, SK Özdemir, Ö Yildiz, D Mungan, ... Allergologia et Immunopathologia 41 (1), 30-36
Late onset anaphylaxis in a hydatid cyst case presenting with chronic urticaria I Yilmaz, O Aydin, A Okoh, Z Misirligil Case Reports in Medicine 2013
Coexistence of allergic bronchopulmonary aspergillosis and atopic dermatitis: Is total IgE level useful to identify relapses of allergic bronchopulmonary aspergillosis? I Yılmaz, O Aydın, SK Ozdemir, D Mungan, G Celik Allergologia et Immunopathologia 41 (4), 281-283
Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey S Bavbek, I Yılmaz, G Çelik, Ö Aydın, FÖ Erkekol, A Orman, E Kurt, ... Allergologia et immunopathologia 40 (4), 225-230
Attitudes and knowledge for smoking among university students. Ș Akçay, AG Dİlektașlı, İ Budakoğlu, I Yılmaz, Ö Erdem Türkiye Klinikleri Tıp Bilimleri Dergisi 29 (3), 611-617
Ağır Astım ve Biyolojik Tedaviler. Prof. Dr. İnsu Yılmaz. Dünya Tıp Kitabevi. Basım Yılı:2021. Sayfa Sayısı: 120. ISBN: 97860596156002021
Bronş Provokasyon Testleri. Prof. Dr. İnsu Yılmaz. Yayınevi: Dünya Tıp Kitabevi. Basım Yılı: 2017. Sayfa Sayısı: 148. ISBN: 9786059615112